Clinical Trial Update: Tapinarof for Cutaneous Lupus Erythematosus [EARLY_Phase 1]

View source ↗

Summary

Northwestern University reports an early Phase 1 trial evaluating tapinarof for cutaneous lupus erythematosus; the study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• Tapinarof (tapinarof)

Snippet

Sponsor: Northwestern University | Conditions: Cutaneous Lupus Erythematosus | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION